These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 30504345)

  • 1. Activity of eltrombopag in severe aplastic anemia.
    Scheinberg P
    Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):450-456. PubMed ID: 30504345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of eltrombopag in severe aplastic anemia.
    Scheinberg P
    Blood Adv; 2018 Nov; 2(21):3054-3062. PubMed ID: 30425070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of efficacy of eltrombopag combined with immunosuppression in the treatment of severe aplastic anemia and very severe aplastic anemia: real-world data and evidence.
    Li X; Shangguan X; Wang H; Wang Q; Zhang Y; Han B; Liu R; Zhang F; Fu R; Lin Z; Miao M; Ma X; Lei M; Wu D; Liu L
    Ann Hematol; 2024 Sep; 103(9):3483-3491. PubMed ID: 39088061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eltrombopag Added to Standard Immunosuppression for Aplastic Anemia.
    Townsley DM; Scheinberg P; Winkler T; Desmond R; Dumitriu B; Rios O; Weinstein B; Valdez J; Lotter J; Feng X; Desierto M; Leuva H; Bevans M; Wu C; Larochelle A; Calvo KR; Dunbar CE; Young NS
    N Engl J Med; 2017 Apr; 376(16):1540-1550. PubMed ID: 28423296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eltrombopag in children with severe aplastic anemia.
    Lesmana H; Jacobs T; Boals M; Gray N; Lewis S; Ding J; Kang G; Hale M; Weiss M; Reiss U; Wang W; Wlodarski M
    Pediatr Blood Cancer; 2021 Aug; 68(8):e29066. PubMed ID: 33855784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia.
    Peffault de Latour R; Kulasekararaj A; Iacobelli S; Terwel SR; Cook R; Griffin M; Halkes CJM; Recher C; Barraco F; Forcade E; Vallejo JC; Drexler B; Mear JB; Smith AE; Angelucci E; Raymakers RAP; de Groot MR; Daguindau E; Nur E; Barcellini W; Russell NH; Terriou L; Iori AP; La Rocca U; Sureda A; Sánchez-Ortega I; Xicoy B; Jarque I; Cavenagh J; Sicre de Fontbrune F; Marotta S; Munir T; Tjon JML; Tavitian S; Praire A; Clement L; Rabian F; Marano L; Hill A; Palmisani E; Muus P; Cacace F; Frieri C; van Lint MT; Passweg JR; Marsh JCW; Socié G; Mufti GJ; Dufour C; Risitano AM;
    N Engl J Med; 2022 Jan; 386(1):11-23. PubMed ID: 34986284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Advances and Long-Term Results of Medical Treatment of Acquired Aplastic Anemia: Are Patients Cured?
    Scheinberg P
    Hematol Oncol Clin North Am; 2018 Aug; 32(4):609-618. PubMed ID: 30047414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nationwide survey on the use of eltrombopag in patients with severe aplastic anemia: a report on behalf of the French Reference Center for Aplastic Anemia.
    Lengline E; Drenou B; Peterlin P; Tournilhac O; Abraham J; Berceanu A; Dupriez B; Guillerm G; Raffoux E; de Fontbrune FS; Ades L; Balsat M; Chaoui D; Coppo P; Corm S; Leblanc T; Maillard N; Terriou L; Socié G; de Latour RP
    Haematologica; 2018 Feb; 103(2):212-220. PubMed ID: 29170252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eltrombopag added to immunosuppression for children with treatment-naïve severe aplastic anaemia.
    Groarke EM; Patel BA; Gutierrez-Rodrigues F; Rios O; Lotter J; Baldoni D; St Pierre A; Shalhoub R; Wu CO; Townsley DM; Young NS
    Br J Haematol; 2021 Feb; 192(3):605-614. PubMed ID: 33410523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eltrombopag, oral immunosuppressant and androgen combination therapy in twelve patients with refractory severe aplastic anemia.
    Gao Q; Zhang L; Zhao X; Zhu Y; Peng G; Li Y; Li Y; Li J; Song L; Ye L; Fan H; Zhou K; Yang W; Yang Y; Jing L; Zhang F
    Hematology; 2020 Dec; 25(1):341-347. PubMed ID: 32915111
    [No Abstract]   [Full Text] [Related]  

  • 11. Eltrombopag in aplastic anemia.
    Desmond R; Townsley DM; Dunbar C; Young NS
    Semin Hematol; 2015 Jan; 52(1):31-7. PubMed ID: 25578417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of eltrombopag in the first-line therapy of severe aplastic anemia in children.
    Jie M; Fu L; Li S; He Y; Yao J; Cheng X; Zhang L; Zheng J; Zhang R; Wu R
    Pediatr Hematol Oncol; 2021 Oct; 38(7):647-657. PubMed ID: 33798022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eltrombopag for the treatment of aplastic anemia: current perspectives.
    Lum SH; Grainger JD
    Drug Des Devel Ther; 2016; 10():2833-2843. PubMed ID: 27695288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy and safety of eltrombopag in aplastic anemia: A multi-center survey in China].
    Yang WR; Han B; Chang H; Wu BY; Meng FK; Ji DX; Li YM; Zheng ZJ; Fei Y; Shen JP; Hu P; Ding XQ; Zhang P; Wang YQ; Zhang FK
    Zhonghua Xue Ye Xue Za Zhi; 2020 Nov; 41(11):890-895. PubMed ID: 33333690
    [No Abstract]   [Full Text] [Related]  

  • 15. A real-word experience of eltrombopag plus rabbit antithymocyte immunoglobulin-based IST in Chinese patients with severe aplastic anemia.
    Jin Y; Li R; Lin S; Jia J; Yang Y; Zhang D; He G; Li J
    Ann Hematol; 2022 Nov; 101(11):2413-2419. PubMed ID: 36028583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal evaluation of eltrombopag in paediatric acquired severe aplastic anaemia.
    Filippidou M; Avgerinou G; Tsipou H; Tourkantoni N; Katsibardi K; Vlachou A; Roka K; Solomou E; Kattamis A
    Br J Haematol; 2020 Aug; 190(3):e157-e159. PubMed ID: 32529633
    [No Abstract]   [Full Text] [Related]  

  • 17. Eltrombopag in Combination with Rabbit Anti-thymocyte Globulin/Cyclosporine A in Immunosuppressive Therapy-naïve Patients with Aplastic Anemia in Japan.
    Imada K; Obara N; Iida H; Imajo K; Maeda T; Usuki K; Fanghong Z; Hombo Y; Tajima T; Kumagai A; Matsuda A; Nakao S
    Intern Med; 2021 Apr; 60(8):1159-1168. PubMed ID: 33229810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic review and meta-analysis of the safety and efficacy of anti-thymocyte globulin combined with eltrombopag in the treatment of severe aplastic anemia.
    Zhang J; Wu Y; Liu J; Han S; Chen L; Wang H; Peng Y
    Ann Palliat Med; 2021 May; 10(5):5549-5560. PubMed ID: 34107711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of immunosuppressive therapy with or without eltrombopag in pediatric patients with acquired aplastic anemia: A Chinese retrospective study.
    Fang M; Song H; Zhang J; Li S; Shen D; Tang Y
    Pediatr Hematol Oncol; 2021 Oct; 38(7):633-646. PubMed ID: 33724146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel therapeutic choices in immune aplastic anemia.
    Scheinberg P
    F1000Res; 2020; 9():. PubMed ID: 32953089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.